Meth-A cells transfected with the human IL-17 gene can induce tumor-specific antitumor immunity by augmenting the expression of major histocompatibility complex (MHC) class I and II antigens; this antitumor immunity may be mediated by CD4+ and CD8+ T cells [76]. The gene discussed is CD4; the disease is neoplasm.